Celularity Inc — Investor Relations & Filings
Celularity Inc. is a clinical and commercial-stage biotechnology company specializing in cellular and regenerative medicine. The company develops and commercializes therapies derived from the postpartum human placenta. Its core focus is on creating off-the-shelf, allogeneic cell therapies, including genetically modified and unmodified Natural Killer (NK) cells, CAR T-cells, and mesenchymal-like adherent stromal cells (MLASCs). These therapeutic programs target a range of conditions, including cancer, immune disorders, and aging-related degenerative diseases. In addition to its clinical pipeline, Celularity markets a suite of commercial placenta-derived biomaterial products. The company leverages the unique biological properties of the placenta to develop accessible treatments for significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Celularity Inc (0001752828) (Filer) | 2026-04-21 | English | |
| SCHEDULE 13G/A Filing | 2026-02-11 | English | |
| 8-K Filing | 2026-01-21 | English | |
| 4/A | 2026-01-15 | English | |
| 4/A | 2026-01-15 | English | |
| 4/A | 2026-01-15 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 34774203 | 8-K - Celularity Inc (0001752828) (Filer) | 2026-04-21 | English | ||
| 31588087 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 31588249 | 8-K Filing | 2026-01-21 | English | ||
| 13133909 | 4/A | 2026-01-15 | English | ||
| 13133910 | 4/A | 2026-01-15 | English | ||
| 13133912 | 4/A | 2026-01-15 | English | ||
| 13133911 | 4/A | 2026-01-15 | English | ||
| 13133913 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133914 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133915 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133916 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133917 | 424B3 | 2026-01-08 | English | ||
| 13133918 | Regulatory Filings 2026 | 2026-01-08 | English | ||
|
2025
2 filings
| |||||
| 13133919 | S-1 | 2025-12-31 | English | ||
| 13133920 | 4 | 2025-12-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Entrada Therapeutics, Inc.
Clinical-stage biopharma developing EEV-based therapies for…
|
TRDA | US | Manufacturing |
|
Enwei Pharmaceutical Co., Ltd.
Produces Chinese patent medicines and chemical drugs for gy…
|
301331 | CN | Manufacturing |
|
ENZYCHEM LIFESCIENCES CORPORATION
Develops small molecule therapeutics for cancer, inflammati…
|
183490 | KR | Manufacturing |
|
Enzymatica AB
Develops medical devices for infections based on a propriet…
|
ENZY | SE | Manufacturing |
|
Epitomee Medical Ltd.
Develops ingestible therapeutic devices for chronic disease…
|
EPIT | IL | Manufacturing |
|
EPSILON HEALTHCARE LIMITED
Integrated medicinal cannabis company providing manufacturi…
|
EPN | AU | Manufacturing |
|
EQL Pharma AB
Develops and sells niche generic and specialty medicines, p…
|
EQL | SE | Manufacturing |
|
Erasca, Inc.
A clinical-stage oncology company developing therapies for …
|
ERAS | US | Manufacturing |
|
Eris Lifesciences Limited
Develops and markets branded generic pharmaceuticals for ch…
|
ERIS | IN | Manufacturing |
|
Ernexa Therapeutics Inc.
Biopharmaceutical company developing cell therapies for can…
|
ERNA | US | Manufacturing |
Celularity Inc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34506/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34506 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34506 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34506 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34506}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Celularity Inc (id: 34506)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.